Your browser doesn't support javascript.
loading
RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia.
Matthijssens, Filip; Sharma, Nitesh D; Nysus, Monique; Nickl, Christian K; Kang, Huining; Perez, Dominique R; Lintermans, Beatrice; Van Loocke, Wouter; Roels, Juliette; Peirs, Sofie; Demoen, Lisa; Pieters, Tim; Reunes, Lindy; Lammens, Tim; De Moerloose, Barbara; Van Nieuwerburgh, Filip; Deforce, Dieter L; Cheung, Laurence C; Kotecha, Rishi S; Risseeuw, Martijn Dp; Van Calenbergh, Serge; Takarada, Takeshi; Yoneda, Yukio; van Delft, Frederik W; Lock, Richard B; Merkley, Seth D; Chigaev, Alexandre; Sklar, Larry A; Mullighan, Charles G; Loh, Mignon L; Winter, Stuart S; Hunger, Stephen P; Goossens, Steven; Castillo, Eliseo F; Ornatowski, Wojciech; Van Vlierberghe, Pieter; Matlawska-Wasowska, Ksenia.
Afiliação
  • Matthijssens F; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Sharma ND; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Nysus M; Department of Pediatrics, Division of Hematology-Oncology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA.
  • Nickl CK; Comprehensive Cancer Center, University of New Mexico, Albuquerque, New Mexico, USA.
  • Kang H; Department of Pediatrics, Division of Hematology-Oncology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA.
  • Perez DR; Comprehensive Cancer Center, University of New Mexico, Albuquerque, New Mexico, USA.
  • Lintermans B; Department of Pediatrics, Division of Hematology-Oncology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA.
  • Van Loocke W; Comprehensive Cancer Center, University of New Mexico, Albuquerque, New Mexico, USA.
  • Roels J; Comprehensive Cancer Center, University of New Mexico, Albuquerque, New Mexico, USA.
  • Peirs S; Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA.
  • Demoen L; Comprehensive Cancer Center, University of New Mexico, Albuquerque, New Mexico, USA.
  • Pieters T; University of New Mexico Center for Molecular Discovery, Albuquerque, New Mexico, USA.
  • Reunes L; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Lammens T; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • De Moerloose B; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Van Nieuwerburgh F; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Deforce DL; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Cheung LC; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Kotecha RS; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Risseeuw MD; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Van Calenbergh S; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Takarada T; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Yoneda Y; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • van Delft FW; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Lock RB; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Merkley SD; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Chigaev A; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Sklar LA; Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.
  • Mullighan CG; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Loh ML; Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.
  • Winter SS; Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium.
  • Hunger SP; Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium.
  • Goossens S; Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.
  • Castillo EF; School of Pharmacy and Biomedical Sciences, Curtin University, Perth, Western Australia, Australia.
  • Ornatowski W; Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.
  • Van Vlierberghe P; School of Pharmacy and Biomedical Sciences, Curtin University, Perth, Western Australia, Australia.
  • Matlawska-Wasowska K; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
J Clin Invest ; 131(6)2021 03 15.
Article em En | MEDLINE | ID: mdl-33555272
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Leucemia Base de dados: MEDLINE Assunto principal: Subunidade alfa 1 de Fator de Ligação ao Core / Leucemia-Linfoma Linfoblástico de Células T Precursoras Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Child / Humans Idioma: En Revista: J Clin Invest Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Leucemia Base de dados: MEDLINE Assunto principal: Subunidade alfa 1 de Fator de Ligação ao Core / Leucemia-Linfoma Linfoblástico de Células T Precursoras Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Child / Humans Idioma: En Revista: J Clin Invest Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Bélgica